ATE234359T1 - Fusionsproteine bestehend aus gewebefaktor- kunitzdomäne als inhibitoren des faktors viia - Google Patents

Fusionsproteine bestehend aus gewebefaktor- kunitzdomäne als inhibitoren des faktors viia

Info

Publication number
ATE234359T1
ATE234359T1 AT96940592T AT96940592T ATE234359T1 AT E234359 T1 ATE234359 T1 AT E234359T1 AT 96940592 T AT96940592 T AT 96940592T AT 96940592 T AT96940592 T AT 96940592T AT E234359 T1 ATE234359 T1 AT E234359T1
Authority
AT
Austria
Prior art keywords
factor
kunitzdomain
inhibitors
fusion proteins
proteins consisting
Prior art date
Application number
AT96940592T
Other languages
English (en)
Inventor
Robert F Kelley
Robert A Lazarus
Geoffrey F Lee
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/566,800 external-priority patent/US5736364A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE234359T1 publication Critical patent/ATE234359T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96940592T 1995-12-01 1996-11-22 Fusionsproteine bestehend aus gewebefaktor- kunitzdomäne als inhibitoren des faktors viia ATE234359T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56645995A 1995-12-01 1995-12-01
US08/566,800 US5736364A (en) 1995-12-04 1995-12-04 Factor viia inhibitors
PCT/US1996/018756 WO1997020939A1 (en) 1995-12-01 1996-11-22 TISSUE FACTOR - KUNITZ DOMAIN FUSION PROTEINS AS FACTOR VIIa INHIBITORS

Publications (1)

Publication Number Publication Date
ATE234359T1 true ATE234359T1 (de) 2003-03-15

Family

ID=27074189

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96940592T ATE234359T1 (de) 1995-12-01 1996-11-22 Fusionsproteine bestehend aus gewebefaktor- kunitzdomäne als inhibitoren des faktors viia

Country Status (8)

Country Link
EP (1) EP0866870B1 (de)
AT (1) ATE234359T1 (de)
AU (1) AU1023497A (de)
DE (1) DE69626671T2 (de)
DK (1) DK0866870T3 (de)
ES (1) ES2195025T3 (de)
PT (1) PT866870E (de)
WO (1) WO1997020939A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214333B1 (en) * 1997-07-08 2001-04-10 Texas Heart Institute Vasoprotective recombinant adenovirus vector containing a human TFPI gene
EP1105475A1 (de) 1998-07-15 2001-06-13 Genentech, Inc. Proteinvarianten von gewebsfaktoren mit erhöhter affinität für koagulationsfaktor fvii/fviia
IL147269A0 (en) 1999-07-02 2002-08-14 Genentech Inc FVIIa ANTAGONISTS
ATE279437T1 (de) * 1999-08-06 2004-10-15 Genentech Inc Peptidantagonisten des faktors viia
US6905683B2 (en) 2000-05-03 2005-06-14 Novo Nordisk Healthcare A/G Human coagulation factor VII variants
CZ2003611A3 (cs) 2000-09-13 2003-08-13 Novo Nordisk A/S Varianty lidského koagulačního faktoru VII
WO2002038162A1 (en) 2000-11-09 2002-05-16 The Scripps Research Institute MODIFIED FACTOR VIIa
US7052868B2 (en) 2001-09-27 2006-05-30 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
US6960657B2 (en) 2001-11-02 2005-11-01 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
US7164002B2 (en) 2002-02-06 2007-01-16 Genentech, Inc. FVIIa antagonists
US6911323B2 (en) 2002-09-25 2005-06-28 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
ATE547519T1 (de) 2003-09-09 2012-03-15 Novo Nordisk Healthcare Ag Gerinnungsfaktor-vii-polypeptide
ATE485052T1 (de) * 2006-04-07 2010-11-15 Novo Nordisk Healthcare Ag Kovalenter faktor vii-gewebefaktor-komplex
CA3198102A1 (en) * 2020-10-07 2022-04-14 Dren Bio, Inc. Anti-dectin-1 antibodies and methods of use thereof
US20240108688A1 (en) 2020-11-20 2024-04-04 Universitätsmedizin Der Johannes Gutenberg-Universität Mainz Inhibitors of the tissue factor-protease activated receptor 2 (TF-PAR2) signaling pathway for use in the treatment or prevention of heart failure (HF) and associated or resulting diseases
GB202402535D0 (en) * 2024-02-22 2024-04-10 Imperial College Innovations Ltd Fusion proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2086521T3 (es) * 1990-01-25 1996-07-01 Univ Washington Proteina hibrida laci-factor x.
US5346991A (en) * 1991-06-13 1994-09-13 Genentech, Inc. Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders
WO1994028017A1 (en) * 1993-06-01 1994-12-08 The Scripps Research Institute Human mutant tissue factor compositions useful as tissue factor antagonists
US5795954A (en) * 1994-03-04 1998-08-18 Genentech, Inc. Factor VIIa inhibitors from Kunitz domain proteins

Also Published As

Publication number Publication date
EP0866870B1 (de) 2003-03-12
DE69626671T2 (de) 2004-03-18
AU1023497A (en) 1997-06-27
DK0866870T3 (da) 2003-06-23
WO1997020939A1 (en) 1997-06-12
EP0866870A1 (de) 1998-09-30
ES2195025T3 (es) 2003-12-01
PT866870E (pt) 2003-08-29
DE69626671D1 (de) 2003-04-17

Similar Documents

Publication Publication Date Title
ATE234359T1 (de) Fusionsproteine bestehend aus gewebefaktor- kunitzdomäne als inhibitoren des faktors viia
DK0760661T3 (da) Farmaceutiske sammensætninger omfattende en opiat-antagonist og calciumsalte, deres anvendelse til behandling af endorfin-m
CY1108725T1 (el) Συνδυασμος ανταγωνιστου-nmda και αναστολεων ακετυλοχολινεστερασης δια την θεραπειαν της νοσου alzheimer
DE69805973D1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
ES2133807T3 (es) Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
BR9909248A (pt) Inibidores de enzima
BR0110506A (pt) Uso de inibidores de il-18 para o tratamento e/ou prevenção da aterosclerose
YU16399A (sh) ) UPOTREBA INHIBITOR H +, K+ - ATP- aze I FARMACEUTSKA FORMULACIJA ZA SIMULTANU, SEPARATNU ILI SEKVENCIJALNU UPOTREBU, KOJA SADRZI INHIBITOR H +, K+-ATP- aze I GLUKOKORTIKOID INHIBITOR H +, K+- ATP- aze
ATE266420T1 (de) Kombinationspräparat, das selektive nmda nr2b- antagonisten und cox-2 inhibitoren enthält
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
BR9809848A (pt) Composição
NO980296L (no) Forbedrede terapeutiske midler
DK0652900T3 (da) Thrombininhibitorer
DE69819539D1 (de) Antithrombotische mittel
SE9802209D0 (sv) Novel compounds
BR0108980A (pt) Aplicação e formulação farmacêuticas compreendendo inibidor de reabsorção de norepinefrina
BR0110902A (pt) Inibidores de mmp-9/mmp-2
NO20001548L (no) Endotelinantagonist og en renin-angiotensinsystem inhibitor som et kombinert preparat
ATE374203T1 (de) Therapeutische verbindungen und verfahren
ES2166816T3 (es) Derivados piridil-imidazolicos y procedimientos para su preparacion.
DE69930844D1 (de) Inhibitoren von mycobakterien
DE69824862D1 (de) Zusammenstellungen zur verbesserten wundheilung
BR0113886A (pt) Composição, composição farmacêutica, tratamento de combinação para prevenir ou inibir a geração ou atividade de trombina num paciente, método para inibir ou prevenir a geração ou atividade de trombina num paciente, uso de uma composição ou tratamento de combinação, uso de uma composição, uso e kit

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0866870

Country of ref document: EP

REN Ceased due to non-payment of the annual fee